Your browser doesn't support javascript.
loading
Author Correction: Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs.
Laham, Amina Jamal; El-Awady, Raafat; Saber-Ayad, Maha; Wang, Ni; Yan, Gang; Boudreault, Julien; Ali, Suhad; Lebrun, Jean-Jacques.
Affiliation
  • Laham AJ; Department of Medicine, Cancer Research Program, McGill University Health Center, Montreal, Quebec, H4A 3J1, Canada.
  • El-Awady R; College of Medicine, University of Sharjah, Sharjah, 27272, United Arab Emirates.
  • Saber-Ayad M; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates.
  • Wang N; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates. relawady@sharjah.ac.ae.
  • Yan G; College of Pharmacy, University of Sharjah, Sharjah, 27272, United Arab Emirates. relawady@sharjah.ac.ae.
  • Boudreault J; College of Medicine, University of Sharjah, Sharjah, 27272, United Arab Emirates.
  • Ali S; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates.
  • Lebrun JJ; Department of Medicine, Cancer Research Program, McGill University Health Center, Montreal, Quebec, H4A 3J1, Canada.
NPJ Precis Oncol ; 8(1): 141, 2024 Jul 08.
Article in En | MEDLINE | ID: mdl-38977910
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: NPJ Precis Oncol Year: 2024 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: NPJ Precis Oncol Year: 2024 Document type: Article Affiliation country: